PE Firms Get Fines Cut For Pharma Co.'s Excessive Pricing
An appeals tribunal upheld on Tuesday a decision that Advanz excessively inflated the price of its thyroid tablets for the National Health Service but cut the fines imposed by the antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article